CHEST 2025: INSIDE LOOK
Learning Theater 1
Sponsored by Sanofi and Regeneron
Join leading pulmonologist Dr. Nicola Hanania as he explores the clinical relevance of exacerbations, lung function loss, and quality-of-life impairment in shaping disease burden. He will also review the latest findings from the Phase 3 BOREAS and NOTUS trials of dupilumab.
Don’t miss your opportunity to hear directly from a global expert in pulmonology during the live audience Q&A following the presentations.
This is a non-CME event and does not qualify for CME or CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2025 conference sessions. This event is not an endorsement by CHEST and does not reflect the views or opinions of CHEST.
Nicola Hanania, MD, MS, FCCP, FACP, FRCP(C), FERS
Baylor College of Medicine
Professor/Chief
Houston, Texas